De novo identification of CD4
Journal
Nature methods
ISSN: 1548-7105
Titre abrégé: Nat Methods
Pays: United States
ID NLM: 101215604
Informations de publication
Date de publication:
24 Apr 2024
24 Apr 2024
Historique:
received:
20
11
2022
accepted:
22
03
2024
medline:
25
4
2024
pubmed:
25
4
2024
entrez:
24
4
2024
Statut:
aheadofprint
Résumé
CD4
Identifiants
pubmed: 38658646
doi: 10.1038/s41592-024-02255-0
pii: 10.1038/s41592-024-02255-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
ID : 1R03DK127447-01
Organisme : U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD)
ID : DP2 OD033187-01
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : 5T32AI089443-14
Informations de copyright
© 2024. The Author(s).
Références
Davis, M. M. & Bjorkman, P. J. T-cell antigen receptor genes and T-cell recognition. Nature 334, 395–402 (1988).
doi: 10.1038/334395a0
pubmed: 3043226
Robins, H. S. et al. Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells. Blood 114, 4099–4107 (2009).
doi: 10.1182/blood-2009-04-217604
pubmed: 19706884
pmcid: 2774550
Qi, Q. et al. Diversity and clonal selection in the human T-cell repertoire. Proc. Natl Acad. Sci. USA 111, 13139–13144 (2014).
doi: 10.1073/pnas.1409155111
pubmed: 25157137
pmcid: 4246948
de Greef, P. C. et al. The naive T-cell receptor repertoire has an extremely broad distribution of clone sizes. eLife 9, e49900 (2020).
doi: 10.7554/eLife.49900
pubmed: 32187010
pmcid: 7080410
Oh, D. Y. & Fong, L. Cytotoxic CD4(+) T cells in cancer: expanding the immune effector toolbox. Immunity 54, 2701–2711 (2021).
doi: 10.1016/j.immuni.2021.11.015
pubmed: 34910940
pmcid: 8809482
Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23, 186–193 (2022).
doi: 10.1038/s41590-021-01122-w
pubmed: 35105982
James, E. A., Pietropaolo, M. & Mamula, M. J. Immune recognition of β-cells: neoepitopes as key players in the loss of tolerance. Diabetes 67, 1035–1042 (2018).
doi: 10.2337/dbi17-0030
pubmed: 29784651
pmcid: 5961411
Pugliese, A. Autoreactive T cells in type 1 diabetes. J. Clin. Invest. 127, 2881–2891 (2017).
doi: 10.1172/JCI94549
pubmed: 28762987
pmcid: 5531393
Spence, A. et al. Revealing the specificity of regulatory T cells in murine autoimmune diabetes. Proc. Natl Acad. Sci. USA 115, 5265–5270 (2018).
doi: 10.1073/pnas.1715590115
pubmed: 29712852
pmcid: 5960284
Joglekar, A. V. & Li, G. T cell antigen discovery. Nat. Methods 18, 873–880 (2021).
doi: 10.1038/s41592-020-0867-z
pubmed: 32632239
Williams, T. et al. Development of T cell lines sensitive to antigen stimulation. J. Immunol. Methods 462, 65–73 (2018).
doi: 10.1016/j.jim.2018.08.011
pubmed: 30165064
pmcid: 8006528
Parish, C. R., Glidden, M. H., Quah, B. J. & Warren, H. S. Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation. Curr. Protoc. Immunol. https://doi.org/10.1002/0471142735.im0409s84 (2009).
doi: 10.1002/0471142735.im0409s84
pubmed: 19235770
Mann, S. E. et al. Multiplex T cell stimulation assay utilizing a T cell activation reporter-based detection system. Front. Immunol. 11, 633 (2020).
doi: 10.3389/fimmu.2020.00633
pubmed: 32328071
pmcid: 7160884
Bercovici, N., Duffour, M. T., Agrawal, S., Salcedo, M. & Abastado, J. P. New methods for assessing T-cell responses. Clin. Diagn. Lab Immunol. 7, 859–864 (2000).
doi: 10.1128/CDLI.7.6.859-864.2000
pubmed: 11063487
pmcid: 95974
Zhang, S. Q. et al. High-throughput determination of the antigen specificities of T cell receptors in single cells. Nat. Biotechnol. https://doi.org/10.1038/nbt.4282 (2018).
doi: 10.1038/nbt.4282
pubmed: 30475349
pmcid: 6535376
Newell, E. W., Klein, L. O., Yu, W. & Davis, M. M. Simultaneous detection of many T-cell specificities using combinatorial tetramer staining. Nat. Methods 6, 497–499 (2009).
doi: 10.1038/nmeth.1344
pubmed: 19543286
pmcid: 2731062
Klenerman, P., Cerundolo, V. & Dunbar, P. R. Tracking T cells with tetramers: new tales from new tools. Nat. Rev. Immunol. 2, 263–272 (2002).
doi: 10.1038/nri777
pubmed: 12001997
Dolton, G. et al. More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers. Immunology 146, 11–22 (2015).
doi: 10.1111/imm.12499
pubmed: 26076649
pmcid: 4552497
Novak, E. J., Liu, A. W., Nepom, G. T. & Kwok, W. W. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J. Clin. Invest. 104, R63–R67 (1999).
doi: 10.1172/JCI8476
pubmed: 10606632
pmcid: 480919
Nepom, G. T. MHC class II tetramers. J. Immunol. 188, 2477–2482 (2012).
doi: 10.4049/jimmunol.1102398
pubmed: 22389204
Vollers, S. S. & Stern, L. J. Class II major histocompatibility complex tetramer staining: progress, problems, and prospects. Immunology 123, 305–313 (2008).
doi: 10.1111/j.1365-2567.2007.02801.x
pubmed: 18251991
pmcid: 2433336
Rius, C. et al. Peptide-MHC class I tetramers can fail to detect relevant functional T cell clonotypes and underestimate antigen-reactive T cell populations. J. Immunol. 200, 2263–2279 (2018).
doi: 10.4049/jimmunol.1700242
pubmed: 29483360
pmcid: 5857646
Boder, E. T. & Wittrup, K. D. Yeast surface display for screening combinatorial polypeptide libraries. Nat. Biotechnol. 15, 553–557 (1997).
doi: 10.1038/nbt0697-553
pubmed: 9181578
Wen, F. & Zhao, H. Construction and screening of an antigen-derived peptide library displayed on yeast cell surface for CD4
doi: 10.1007/978-1-62703-589-7_15
pubmed: 23963942
Wen, F., Esteban, O. & Zhao, H. Rapid identification of CD4
doi: 10.1016/j.jim.2008.03.008
pubmed: 18448115
Birnbaum, M. E. et al. Deconstructing the peptide-MHC specificity of T cell recognition. Cell 157, 1073–1087 (2014).
doi: 10.1016/j.cell.2014.03.047
pubmed: 24855945
pmcid: 4071348
Joglekar, A. V. et al. T cell antigen discovery via signaling and antigen-presenting bifunctional receptors. Nat. Methods 16, 191–198 (2019).
doi: 10.1038/s41592-018-0304-8
pubmed: 30700902
pmcid: 6755906
Kisielow, J., Obermair, F.-J. & Kopf, M. Deciphering CD4
doi: 10.1038/s41590-019-0335-z
pubmed: 30858620
Kula, T. et al. T-Scan: a genome-wide method for the systematic discovery of T cell epitopes. Cell 178, 1016–1028 (2019).
doi: 10.1016/j.cell.2019.07.009
pubmed: 31398327
pmcid: 6939866
Li, G. et al. T cell antigen discovery via trogocytosis. Nat. Methods 16, 183–190 (2019).
doi: 10.1038/s41592-018-0305-7
pubmed: 30700903
pmcid: 6719556
Sharma, G., Rive, C. M. & Holt, R. A. Rapid selection and identification of functional CD8
doi: 10.1038/s41467-019-12444-7
pubmed: 31591401
pmcid: 6779888
Dobson, C. S. et al. Antigen identification and high-throughput interaction mapping by reprogramming viral entry. Nat. Methods 19, 449–460 (2022).
doi: 10.1038/s41592-022-01436-z
pubmed: 35396484
pmcid: 9012700
Jyothi, M. D., Flavell, R. A. & Geiger, T. L. Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes. Nat. Biotechnol. 20, 1215–1220 (2002).
doi: 10.1038/nbt758
pubmed: 12426577
Obermair, F. J. et al. High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape. Sci. Adv. 8, eabl5394 (2022).
doi: 10.1126/sciadv.abl5394
pubmed: 35486722
pmcid: 9054008
Dezfulian, M. H. et al. TScan-II: a genome-scale platform for the de novo identification of CD4(+) T cell epitopes. Cell 186, 5569–5586 (2023).
doi: 10.1016/j.cell.2023.10.024
pubmed: 38016469
Yu, B. et al. Engineered cell entry links receptor biology with single-cell genomics. Cell 185, 4904–4920 (2022).
doi: 10.1016/j.cell.2022.11.016
pubmed: 36516854
Dash, P. et al. Quantifiable predictive features define epitope-specific T cell receptor repertoires. Nature 547, 89–93 (2017).
doi: 10.1038/nature22383
pubmed: 28636592
pmcid: 5616171
Glanville, J. et al. Identifying specificity groups in the T cell receptor repertoire. Nature 547, 94–98 (2017).
doi: 10.1038/nature22976
pubmed: 28636589
pmcid: 5794212
Schattgen, S. A. et al. Integrating T cell receptor sequences and transcriptional profiles by clonotype neighbor graph analysis (CoNGA). Nat. Biotechnol. 40, 54–63 (2022).
doi: 10.1038/s41587-021-00989-2
pubmed: 34426704
Pogorelyy, M. V. et al. Resolving SARS-CoV-2 CD4
doi: 10.1016/j.xcrm.2022.100697
pubmed: 35841887
pmcid: 9247234
Robertson, J. M., Jensen, P. E. & Evavold, B. D. DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J. Immunol. 164, 4706–4712 (2000).
doi: 10.4049/jimmunol.164.9.4706
pubmed: 10779776
Buzas, E. I. et al. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice. J. Immunol. 155, 2679–2687 (1995).
doi: 10.4049/jimmunol.155.5.2679
pubmed: 7544381
Judkowski, V. et al. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J. Immunol. 166, 908–917 (2001).
doi: 10.4049/jimmunol.166.2.908
pubmed: 11145667
Tait, B. D. Genetic susceptibility to type I diabetes: a review. J. Autoimmun. 3, 3–11 (1990).
doi: 10.1016/S0896-8411(09)90003-8
pubmed: 2187458
Noble, J. A. et al. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am. J. Hum. Genet 59, 1134–1148 (1996).
pubmed: 8900244
pmcid: 1914851
Michels, A. W. et al. Islet-derived CD4 T cells targeting proinsulin in human autoimmune diabetes. Diabetes 66, 722–734 (2017).
doi: 10.2337/db16-1025
pubmed: 27920090
Hao, Z. et al. Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. Immunity 29, 615–627 (2008).
doi: 10.1016/j.immuni.2008.07.016
pubmed: 18835195
pmcid: 3470429
Matou-Nasri, S. et al. CD95-mediated apoptosis in Burkitt’s lymphoma B-cells is associated with Pim-1 down-regulation. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 239–252 (2017).
doi: 10.1016/j.bbadis.2016.09.012
pubmed: 27641442
Rathmell, J. C. et al. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376, 181–184 (1995).
doi: 10.1038/376181a0
pubmed: 7603571
Vita, R. et al. The Immune Epitope Database (IEDB): 2018 update. Nucleic Acids Res. 47, D339–D343 (2019).
doi: 10.1093/nar/gky1006
pubmed: 30357391
Wan, X. et al. The MHC-II peptidome of pancreatic islets identifies key features of autoimmune peptides. Nat. Immunol. 21, 455–463 (2020).
doi: 10.1038/s41590-020-0623-7
pubmed: 32152506
pmcid: 7117798
Baker, R. L. et al. CD4 T cells reactive to hybrid insulin peptides are indicators of disease activity in the NOD mouse. Diabetes 67, 1836–1846 (2018).
doi: 10.2337/db18-0200
pubmed: 29976617
pmcid: 6110316
Amdare, N., Purcell, A. W. & DiLorenzo, T. P. Noncontiguous T cell epitopes in autoimmune diabetes: From mice to men and back again. J. Biol. Chem. 297, 100827 (2021).
doi: 10.1016/j.jbc.2021.100827
pubmed: 34044020
pmcid: 8233151
Stadinski, B. D. et al. Chromogranin A is an autoantigen in type 1 diabetes. Nat. Immunol. 11, 225–231 (2010).
doi: 10.1038/ni.1844
pubmed: 20139986
pmcid: 3166626
Parras, D., Sole, P., Delong, T., Santamaria, P. & Serra, P. Recognition of multiple hybrid insulin peptides by a single highly diabetogenic T-cell receptor. Front. Immunol. 12, 737428 (2021).
doi: 10.3389/fimmu.2021.737428
pubmed: 34527002
pmcid: 8435627
Ramirez, L. & Hamad, A. R. Status of autoimmune diabetes 20-year after generation of BDC2.5-TCR transgenic non-obese diabetic mouse. World J. Diabetes 4, 88–91 (2013).
doi: 10.4239/wjd.v4.i4.88
pubmed: 23961318
pmcid: 3746090
Lee, T., Sprouse, M. L., Banerjee, P., Bettini, M. & Bettini, M. L. Ectopic expression of self-antigen drives regulatory T cell development and not deletion of autoimmune T cells. J. Immunol. 199, 2270–2278 (2017).
doi: 10.4049/jimmunol.1700207
pubmed: 28835461
Wiles, T. A. et al. Identification of hybrid insulin peptides (HIPs) in mouse and human islets by mass spectrometry. J. Proteome Res. 18, 814–825 (2019).
doi: 10.1021/acs.jproteome.8b00875
pubmed: 30585061
pmcid: 7597855
Pearson, J. A., Wong, F. S. & Wen, L. The importance of the non obese diabetic (NOD) mouse model in autoimmune diabetes. J. Autoimmun. 66, 76–88 (2016).
doi: 10.1016/j.jaut.2015.08.019
pubmed: 26403950
Prasad, S., Kohm, A. P., McMahon, J. S., Luo, X. & Miller, S. D. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading. J. Autoimmun. 39, 347–353 (2012).
doi: 10.1016/j.jaut.2012.04.005
pubmed: 22647732
pmcid: 3434243
Zakharov, P. N., Hu, H., Wan, X. & Unanue, E. R. Single-cell RNA sequencing of murine islets shows high cellular complexity at all stages of autoimmune diabetes. J. Exp. Med. 217, e20192362 (2020).
doi: 10.1084/jem.20192362
pubmed: 32251514
pmcid: 7971127
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 (2021).
doi: 10.1016/j.cell.2021.04.048
pubmed: 34062119
pmcid: 8238499
Borcherding, N., Bormann, N. L. & Kraus, G. scRepertoire: an R-based toolkit for single-cell immune receptor analysis. F1000Res 9, 47 (2020).
doi: 10.12688/f1000research.22139.1
pubmed: 32789006
pmcid: 7400693
Baker, F. J., Lee, M., Chien, Y. H. & Davis, M. M. Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice. Proc. Natl Acad. Sci. USA 99, 9374–9379 (2002).
doi: 10.1073/pnas.142284899
pubmed: 12082183
pmcid: 123148
Galley, K. A. & Danska, J. S. Peri-islet infiltrates of young non-obese diabetic mice display restricted TCR β-chain diversity. J. Immunol. 154, 2969–2982 (1995).
doi: 10.4049/jimmunol.154.6.2969
pubmed: 7533189
Grebinoski, S. et al. Autoreactive CD8(+) T cells are restrained by an exhaustion-like program that is maintained by LAG3. Nat. Immunol. 23, 868–877 (2022).
doi: 10.1038/s41590-022-01210-5
pubmed: 35618829
pmcid: 9179227
Rahimikollu, J. et al. SLIDE: significant latent factor interaction discovery and exploration across biological domains. Nat. Methods https://doi.org/10.1038/s41592-024-02175-z (2024).
doi: 10.1038/s41592-024-02175-z
pubmed: 38374265
Giudicelli, V., Chaume, D. & Lefranc, M. P. IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res. 33, D256–D261 (2005).
doi: 10.1093/nar/gki010
pubmed: 15608191
Chiou, S. H. et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity 54, 586–602 (2021).
doi: 10.1016/j.immuni.2021.02.014
pubmed: 33691136
pmcid: 7960510
Baker, R. L., Jamison, B. L. & Haskins, K. Hybrid insulin peptides are neo-epitopes for CD4 T cells in autoimmune diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 26, 195–200 (2019).
doi: 10.1097/MED.0000000000000490
pubmed: 31166225
pmcid: 6830731
Gioia, L. et al. Position beta57 of I-A(g7) controls early anti-insulin responses in NOD mice, linking an MHC susceptibility allele to type 1 diabetes onset. Sci. Immunol. 4, eaaw6329 (2019).
doi: 10.1126/sciimmunol.aaw6329
pubmed: 31471352
pmcid: 6816460
Wenzlau, J. M. et al. Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes. Front. Immunol. 13, 926650 (2022).
doi: 10.3389/fimmu.2022.926650
pubmed: 36032090
pmcid: 9399855
Balakrishnan, S., Kumar, P. & Prabhakar, B. S. Post-translational modifications contribute to neoepitopes in Type-1 diabetes: challenges for inducing antigen-specific tolerance. Biochim Biophys. Acta Proteins Proteom. 1868, 140478 (2020).
doi: 10.1016/j.bbapap.2020.140478
pubmed: 32599298
Buitinga, M. et al. Inflammation-Induced citrullinated glucose-regulated protein 78 elicits immune responses in human type 1 diabetes. Diabetes 67, 2337–2348 (2018).
doi: 10.2337/db18-0295
pubmed: 30348823
pmcid: 6973547
Almagro Armenteros, J. J. et al. SignalP 5.0 improves signal peptide predictions using deep neural networks. Nat. Biotechnol. 37, 420–423 (2019).
doi: 10.1038/s41587-019-0036-z
pubmed: 30778233
Cooper, A. R. et al. Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration. J. Virol. Methods 177, 1–9 (2011).
doi: 10.1016/j.jviromet.2011.06.019
pubmed: 21784103
pmcid: 4276401
Szymczak, A. L. et al. Correction of multi-gene deficiency in vivo using a single ‘self-cleaving’ 2A peptide-based retroviral vector. Nat. Biotechnol. 22, 589–594 (2004).
doi: 10.1038/nbt957
pubmed: 15064769